PREDICTION OF ANTI-DIABETIC ALOGLIPTIN STABILITY BY ISOTHERMAL STUDIES
Alogliptin (ALG) benzoate is an oral hypoglycemic drug that works as a DPP-4 inhibitor to prevent incretin degradation. Forced stability studies use high temperatures to decompose drugs and estimate their behavior at low temperatures. We aimed to evaluate the thermal stability of ALG using two techn...
Main Authors: | Charise Dallazem Bertol, Gabriel Felimberti, Karini da Rosa, Eliamar Ceresoli Rizzon, Rafael Nicolay Pereira, Luiz Carlos Kreutz, Pedro Eduardo Froelich |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Química
2023-10-01
|
Series: | Química Nova |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422023000800765&lng=en&tlng=en |
Similar Items
-
CARDIOVASCULAR SAFETY OF GLIPTINS. FOCUS ON ALOGLIPTIN
by: N. A. Petunina, et al.
Published: (2017-12-01) -
Formulation and Optimization of Alogliptin-Loaded Polymeric Nanoparticles: In Vitro to In Vivo Assessment
by: Dibyalochan Mohanty, et al.
Published: (2022-07-01) -
Possibilities of application a fixed combination of alogliptin and pioglitazone for type 2 diabetes mellitus treatment
by: M. V. Shestakova, et al.
Published: (2021-07-01) -
Alogliptin after acute coronary syndrome in patients with type 2 diabetes: a renal function stratified analysis of the EXAMINE trial
by: João Pedro Ferreira, et al.
Published: (2020-06-01) -
Salting-out induced liquid–liquid microextraction for alogliptin benzoate determination in human plasma by HPLC/UV
by: Sherin F. Hammad, et al.
Published: (2021-01-01)